Taking aim at Bcl-xL
Scientists identify a new target for treating age-related eye diseases
Ophthalmology
Novel neuroprotection from Noveome
Data show full complement ST266 biologic offers better neuroprotection than fractionated formats
A hope for fewer injections
Roche's faricimab injected every 16 weeks proves non-inferior to aflibercept injected every eight weeks in patients with “wet” age-related macular degeneration
A new way to view wet AMD
New insights into age-related macular degeneration could lead to better treatments
miRagen brings in Viridian Therapeutics
The acquisition includes clinical stage anti-IGF-1R monoclonal antibody VRDN-001, which is intended for treatment of thyroid eye disease
Vanda gains IND approval for CFTR activator VSJ-110
Vanda Pharmaceuticals gains FDA approval on their IND for VSJ-110 to treat allergic conjunctivitis
Researchers discover astrocytes could be behind nerve death
Astrocytes could play a critical role in nerve death in neurodegenerative diseases
Investigating stromal vascular fraction therapy for COVID-19
San Diego Academy of Regenerative Therapies publishes article about first-in-human clinical trial using adipose-derived SVF to treat post-COVID-19 patients suffering lung damage
Optimal OPTICs
ADVM-022 demonstrates efficacy, durability in OPTIC trial in wet AMD
Usher update
ProQR offers upbeat interim analysis in Phase 1/2 trial of QR-421a for Usher Syndrome
